Board of Directors
The N2 Board of Directors consists of 12 individuals representing the different stakeholders within N2 membership.
Karen Arts
Co-founder
Executive Director Canadian Cancer Clinical Trials Network (3CTN)
Jim Pankovich
Chair
Vice President, Clinical Operations & Drug Development-Qu Biologics Inc.
Patrick Clifford
Treasurer
Director of Research and Innovation, CreateIT Now @ Southlake Innovation Centre – The Research Institute at Southlake
Erin Cherban
Secretary
Chief Research Officer Centre for Health Evaluation & Outcome Sciences (CHÉOS), CIHR Canadian HIV Trials Network (CTN)
Kathy Brodeur-Robb
Board Member
Executive Director C-17 Council
Scott Corley
Board Member
Director-Clinical Trial Support Unit, Saskatchewan
Janette Panhuis
Board Member
Chief Operating Officer of the Population Health Research Institute, A Joint Institute of HHS and McMaster University
Nancy Camack
Board Member
Director, Clinical Research Administration, Ottawa Hospital Research Institute (OHRI)
Rachel Syme
Vice Chair
Assistant Director, Institute of Cancer Research, CIHR
Tammy Mah-Fraser
Board Member
Director, Platform Operations – Alberta Innovates – Health Solutions
Linda Bennett
Board Member
Project Manager, Marvelle Koffler Breast Centre Research Program